Sturm, I <br/><br/>
Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2001 
 - 2272-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2001.19.8.2272  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Squamous Cell--genetics<br/>Cyclin-Dependent Kinase Inhibitor p16--genetics<br/>Esophageal Neoplasms--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Genes, p53--genetics<br/>Humans<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-bcl-2<br/>Retrospective Studies<br/>Survival Analysis<br/>bcl-2-Associated X Protein